Naproxen chemoprevention induces proliferation of cytotoxic lymphocytes in Lynch Syndrome colorectal mucosa
CONCLUSIONS: Our findings show that daily exposure of naproxen promotes T-cell proliferation in the colonic mucosa, which paves way for developing combination of immunoprevention strategies including naproxen for LS patients.PMID:37207208 | PMC:PMC10189148 | DOI:10.3389/fimmu.2023.1162669
Source: Cancer Control - Category: Cancer & Oncology Authors: Charles M Bowen Nan Deng Laura Reyes-Uribe Edwin Roger Parra Pedro Rocha Luisa M Solis Ignacio I Wistuba Valerie O Sepeda Lana Vornik Marjorie Perloff Eva Szabo Asad Umar Krishna M Sinha Powel H Brown Eduardo Vilar Source Type: research
More News: Aleve | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | HNPCC | Lynch Syndrome | Naproxen | Statistics | Study